Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Elm

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Neurocritical Care|August 14, 2015
Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and DesignKevin N Sheth, Jordan J Elm, Lauren A Beslow, et al.
Translational Neurodegeneration|December 23, 2015
Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of GaitGonzalo J Revuelta, Aaron Embry, Jordan J Elm, et al.
Clinical Trials (London, England)|August 31, 2016
Communicating with participants during the conduct of multi-center clinical trialsErika F Augustine, E Ray Dorsey, Robert A Hauser, et al.
Physiology & Behavior|May 15, 2018
Differences in swallow physiology in patients with left and right hemispheric strokesJanina Wilmskoetter, Bonnie Martin-Harris, William G Pearson, et al.
Journal of the American Heart Association|March 8, 2021
Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT TrialHooman Kamel, Mary Farrant, J Donald Easton, et al.
Annals of Indian Academy of Neurology|June 9, 2026
Relation between Time from Onset to Randomization and Benefit Magnitude in Recent Clinical Trials of Thrombectomy for Patients with Large Ischemic CoresByron J Gajewski, Katherine R Gajewski, Pooja Khatri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 16, 2007
Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experienceJordan J Elm, Cornelia Kamp, Barbara C Tilley, et al.
NPJ Digital Medicine|October 5, 2019
Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson's disease dataJordan J Elm, Margaret Daeschler, Lauren Bataille, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|December 18, 2020
Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status EpilepticusShahriar Zehtabchi, Robert Silbergleit, James M Chamberlain, et al.
Clinical Trials (London, England)|January 21, 2006
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes, Karl Kieburtz, Christopher G Goetz, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Neurocritical Care|August 14, 2015
Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and DesignKevin N Sheth, Jordan J Elm, Lauren A Beslow, et al.
Translational Neurodegeneration|December 23, 2015
Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of GaitGonzalo J Revuelta, Aaron Embry, Jordan J Elm, et al.
Clinical Trials (London, England)|August 31, 2016
Communicating with participants during the conduct of multi-center clinical trialsErika F Augustine, E Ray Dorsey, Robert A Hauser, et al.
Physiology & Behavior|May 15, 2018
Differences in swallow physiology in patients with left and right hemispheric strokesJanina Wilmskoetter, Bonnie Martin-Harris, William G Pearson, et al.
Journal of the American Heart Association|March 8, 2021
Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT TrialHooman Kamel, Mary Farrant, J Donald Easton, et al.
Annals of Indian Academy of Neurology|June 9, 2026
Relation between Time from Onset to Randomization and Benefit Magnitude in Recent Clinical Trials of Thrombectomy for Patients with Large Ischemic CoresByron J Gajewski, Katherine R Gajewski, Pooja Khatri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 16, 2007
Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experienceJordan J Elm, Cornelia Kamp, Barbara C Tilley, et al.
NPJ Digital Medicine|October 5, 2019
Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson's disease dataJordan J Elm, Margaret Daeschler, Lauren Bataille, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|December 18, 2020
Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status EpilepticusShahriar Zehtabchi, Robert Silbergleit, James M Chamberlain, et al.
Clinical Trials (London, England)|January 21, 2006
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes, Karl Kieburtz, Christopher G Goetz, et al.
Pageof 6